Trial Profile
Two-Year Data from a Long-Term Phase IV Study of Recombinant Human Growth Hormone in Short Children Born Small for Gestational Age
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 22 Feb 2016
Price :
$35
*
At a glance
- Drugs Somatropin (Primary)
- Indications Growth disorders
- Focus Adverse reactions; Therapeutic Use
- 22 Feb 2016 New trial record
- 17 Feb 2016 Interim results (n=249) published in the Advances in Therapy.